Scholarly Index
Richard B. Gearry
Waitaki Biosciences (New Zealand); 29,261 total citations; 536 total publications; best world rank #81
Waitaki Biosciences (New Zealand)
29,261Total citations
536Total publications
73H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Inflammatory Bowel Disease | Lifetime | 81 | NZ 1 | 99.43 |
| Microscopic Colitis | Lifetime | 100 | NZ 1 | 99.26 |
| Eosinophilic Esophagitis | Lifetime | 257 | NZ 2 | 98.62 |
| Gastrointestinal motility and disorders | Lifetime | 225 | NZ 1 | 98.21 |
| Acute Lymphoblastic Leukemia research | Lifetime | 533 | NZ 2 | 98.06 |
| Adolescent and Pediatric Healthcare | Lifetime | 319 | NZ 1 | 97.18 |
| Autoimmune and Inflammatory Disorders | Lifetime | 500 | NZ 2 | 93.48 |
| Liver Diseases and Immunity | Lifetime | 868 | NZ 2 | 93.85 |
| Therapeutic Uses of Natural Elements | Lifetime | 944 | NZ 7 | 77.06 |
| Inflammatory Bowel Disease | 2021-2025 | 112 | NZ 1 | 98.67 |
| Microscopic Colitis | 2021-2025 | 104 | NZ 1 | 98.23 |
| Eosinophilic Esophagitis | 2021-2025 | 128 | NZ 2 | 96.95 |
| Gastrointestinal motility and disorders | 2021-2025 | 130 | NZ 4 | 94.75 |
| Diet and metabolism studies | 2021-2025 | 750 | NZ 3 | 93.64 |
| Health, psychology, and well-being | 2021-2025 | 287 | NZ 3 | 79.81 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 960 | NZ 3 | 73.71 |
| Congenital gastrointestinal and neural anomalies | 2021-2025 | 365 | NZ 1 | 68.21 |